NO20014477L - Treatment of osteoarthritis - Google Patents

Treatment of osteoarthritis

Info

Publication number
NO20014477L
NO20014477L NO20014477A NO20014477A NO20014477L NO 20014477 L NO20014477 L NO 20014477L NO 20014477 A NO20014477 A NO 20014477A NO 20014477 A NO20014477 A NO 20014477A NO 20014477 L NO20014477 L NO 20014477L
Authority
NO
Norway
Prior art keywords
osteoarthritis
treatment
Prior art date
Application number
NO20014477A
Other languages
Norwegian (no)
Other versions
NO20014477D0 (en
Inventor
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of NO20014477D0 publication Critical patent/NO20014477D0/en
Publication of NO20014477L publication Critical patent/NO20014477L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20014477A 1999-03-19 2001-09-14 Treatment of osteoarthritis NO20014477L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12530099P 1999-03-19 1999-03-19
PCT/US2000/007072 WO2000056306A1 (en) 1999-03-19 2000-03-17 Treatment of osteoarthritis

Publications (2)

Publication Number Publication Date
NO20014477D0 NO20014477D0 (en) 2001-09-14
NO20014477L true NO20014477L (en) 2001-11-01

Family

ID=22419072

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014477A NO20014477L (en) 1999-03-19 2001-09-14 Treatment of osteoarthritis

Country Status (20)

Country Link
EP (1) EP1169027A4 (en)
JP (2) JP2002539248A (en)
KR (1) KR20020038567A (en)
CN (1) CN1352552A (en)
AU (1) AU773490B2 (en)
BG (1) BG105999A (en)
BR (1) BR0009081A (en)
CA (1) CA2366660A1 (en)
CZ (1) CZ20013284A3 (en)
HK (1) HK1044702A1 (en)
HU (1) HUP0200494A2 (en)
IL (1) IL145238A0 (en)
MX (1) MXPA01009461A (en)
NO (1) NO20014477L (en)
NZ (1) NZ514016A (en)
PL (1) PL365463A1 (en)
SK (1) SK13342001A3 (en)
TR (1) TR200102699T2 (en)
WO (1) WO2000056306A1 (en)
ZA (1) ZA200107682B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US6610887B2 (en) 2001-04-13 2003-08-26 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
ZA836848B (en) * 1982-09-30 1984-05-30 Boots Co Plc Therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
WO1994000114A1 (en) * 1992-06-23 1994-01-06 Sepracor Inc. Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine
JPH07508281A (en) * 1992-06-23 1995-09-14 セプラコア　インコーポレーテッド Methods and compositions for treating depression and other disorders using optically pure (+)sibutramine
JP3862295B2 (en) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 Anti-obesity agent
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
EP0763016B1 (en) * 1994-06-01 2000-01-26 Axys Pharmaceuticals, Inc. Compositions and methods for treating mast-cell mediated conditions
GB9619962D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
MA24500A1 (en) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd CARBOXYLIC ACID SALT DERIVATIVE FROM NAPHTHYRIDINE.

Also Published As

Publication number Publication date
CZ20013284A3 (en) 2002-10-16
NO20014477D0 (en) 2001-09-14
WO2000056306A1 (en) 2000-09-28
JP2002539248A (en) 2002-11-19
EP1169027A4 (en) 2004-10-20
HUP0200494A2 (en) 2002-08-28
CA2366660A1 (en) 2000-09-28
MXPA01009461A (en) 2004-03-19
JP2012051904A (en) 2012-03-15
CN1352552A (en) 2002-06-05
TR200102699T2 (en) 2002-03-21
BR0009081A (en) 2003-03-05
BG105999A (en) 2002-06-28
IL145238A0 (en) 2002-06-30
HK1044702A1 (en) 2002-11-01
KR20020038567A (en) 2002-05-23
AU773490B2 (en) 2004-05-27
EP1169027A1 (en) 2002-01-09
ZA200107682B (en) 2003-06-18
AU3893200A (en) 2000-10-09
SK13342001A3 (en) 2002-04-04
PL365463A1 (en) 2005-01-10
NZ514016A (en) 2001-09-28

Similar Documents

Publication Publication Date Title
NO20013380L (en) 2-aminobenzoxazinone derivatives for the treatment of obesity
NO20014379L (en) Use of Xenon for the Treatment of Neurointoxics
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
NO20013381D0 (en) 2-oxybenzoxazinone derivatives for the treatment of obesity
FI20000863A (en) New treatment procedure
NO20022087L (en) Procedure for the treatment of diabetes
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20022245L (en) Oncolytic combinations for the treatment of cancer
NO20024777L (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20024776L (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NO20020784D0 (en) Medication for the treatment of fractures
NO20013596L (en) Sludge treatment
ATE302165T1 (en) WATER TREATMENT
NO20014477D0 (en) Treatment of osteoarthritis
PT1178984E (en) DERIVATIVES OF 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYLAMIMOME
NO20003529D0 (en) Treatment of dyskinesia
NO20014845D0 (en) Use of arylalkanoylpyridazines
SE0300535L (en) Treatment of burns
PT1232141E (en) ETERIES OF O-DESMETIL-VENLAFAXIN
NO20014476D0 (en) Treatment of hiatial hernia
NO20014093D0 (en) Treatment of infertility
NO20014092L (en) Treatment of infertility
EE200200053A (en) Process of preparation of isoretinoin
IS5873A (en) Treatment of depression
SE9902239D0 (en) Kornisch consisting of several parts